The official Journal of the ACDS
The Dermatitis Journal is the official Journal of the ACDS and is published six times per year. Dermatitis focuses on contact, atopic, occupational, and drug dermatitis, and welcomes manuscript submissions in these fields, with emphasis on reviews, studies, reports, and letters.
Annual sections include Contact Allergen of the Year and Contact Allergen Alternatives, for which papers are chosen or invited by the respective section editor. Other sections unique to the journal are Pearls & Zebras, Product Allergen Watch, and news, features, or meeting abstracts from participating organizations.
Incoming Editor-in-Chief Message – December 16, 2020
I am honored to assume the duties of Editor-in-Chief of Dermatitis beginning on January 1, 2021. This follows in the footsteps of the highly successful leadership of Ponciano (Chito) Cruz, whose duties spanned more than a twenty year timeframe. During this time, the number of submissions to the journal have steadily climbed, and importantly the impact factor has peaked at 4.845. This ranking has earned our journal 11th place among the 68 dermatology journals catalogued by Clarivate, which is its highest ranking ever achieved!
For this tremendous accomplishment, we are indebted to Chito for his sustained effort that has led to our journal rising through the ranks of dermatology journals to its present lofty status. I intend to build on these successes, with expansion of the journal, changes in the editorial board, new features and refinements to our journal and its website to maintain the upward trajectory of Dermatitis.
The current success of the journal has been dependent on the caliber of the scientific manuscripts which are selected for publication, and it is my intention to maintain these high standards. I am grateful to the editorial board for their advice, the reviewers for their efforts in assessing the quality of the manuscripts, and to the authors of the scientific manuscripts for their excellent work, the editorial office for the timely processing of the manuscripts and the collaboration of our current publisher, Wolters Kluwer. Lastly, I am grateful to the members of the American Contact Dermatitis Society and its officers in maintaining our journal. Without your interest and support, there would be no journal.
Our journal’s purpose is to elevate the status of the American Contact Dermatitis Society in the biomedical community of science, and to serve the needs of its members. For this latter point, I ask the members to please contact me with your needs, ideas, interests, criticisms and pathways to further improve Dermatitis. As is apparent from my comments above, the success of Dermatitis has been a collaborative effort, and this certainly will not change.
I wish everyone a safe and prosperous 2021.
Anthony A. Gaspari, MD
PO Box 170513
Irving, TX 75017
Access to the Journals is available at dermatitisjournal.com